ArticleCancer2017

Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies.

Yasmin M Abaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.